Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study

PPMI Investigators

Producción científica › revisión exhaustiva

85 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study'. En conjunto forman una huella única.

Neuroscience